DrugPatentWatch Database Preview
AMPHETAMINE SULFATE Drug Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
When do Amphetamine Sulfate patents expire, and what generic alternatives are available?
Amphetamine Sulfate is a drug marketed by Amneal Pharms, Aurolife Pharma Llc, Granules Pharms, and Lannett. and is included in four NDAs.
The generic ingredient in AMPHETAMINE SULFATE is amphetamine sulfate. There are fifty-five drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the amphetamine sulfate profile page.
US ANDA Litigation and Generic Entry Outlook for Amphetamine Sulfate
A generic version of AMPHETAMINE SULFATE was launched as amphetamine sulfate by AMNEAL PHARMS on December 14th, 2019.
Summary for AMPHETAMINE SULFATE
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Suppliers / Packagers: | 3 |
| Clinical Trials: | 5 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for AMPHETAMINE SULFATE |
| DailyMed Link: | AMPHETAMINE SULFATE at DailyMed |
Recent Clinical Trials for AMPHETAMINE SULFATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Arbor Pharmaceuticals, Inc. | Phase 3 |
| Sarah Morrow | Phase 2/Phase 3 |
| Arbor Pharmaceuticals, Inc. | Phase 4 |
Pharmacology for AMPHETAMINE SULFATE
| Drug Class | Central Nervous System Stimulant |
| Physiological Effect | Central Nervous System Stimulation |
